Adam Laponis, CFO: Eargo EAR Sell · Filed 23/02/22

Trade details

Type: Insider sale
Amount: $154.77
Shares · price: 21 sh · $7.37 a share
Held after: 3,190 sh
Stock: Eargo EAR
Person: Adam LaponisCFO
Trade date: 23/02/17
Filed: 23/02/22
Days to filing: 5 days

Sold 0.7% of holdings

Share of holding sold: 0.7%

Eargo trades, last 26 weeks

What else happened in Eargo around then

Filed or reported within 30 days of the trade day · 23/01/18~23/03/19

Adam Laponis's recent trades

Adam LaponisCFO
Planned saleTwist Bioscience
Planned sale
Twist Bioscience
TWST
$273.3K
1,965 sh
$273.3K
Filed 08/21
Traded 08/21
Adam LaponisCFO
Planned saleTwist Bioscience
Planned sale
Twist Bioscience
TWST
$226.3K
2,399 sh
$226.3K
Filed 07/09
Traded 07/09
Adam LaponisCFO
Sell10b5-1 planTwist Bioscience
Sell10b5-1 plan
Twist Bioscience
TWST
$280K
4,000 sh
$280K
Filed 06/02
Traded 05/29
Adam LaponisCFO
Planned sale10b5-1 planTwist Bioscience
Planned sale10b5-1 plan
Twist Bioscience
TWST
$280K
4,000 sh
$280K
Filed 05/29
Traded 05/29
Adam LaponisCFO
SellTwist Bioscience
Sell
Twist Bioscience
TWST
$107.5K
2,019 sh
$107.5K
Filed 05/26
Traded 05/21

Adam Laponis, CFO — sold $155 of Eargo EAR · 0.7% of holdings | Whalegun